Investigating how BRCA genes affect medulloblastoma responses to DNA damage
Project 4: The BRCA Network in Medulloblastoma Responses to Replication Stress
This study is looking at how certain genes, BRCA1 and BRCA2, affect the way a type of brain tumor called medulloblastoma responds to stress during cell replication, with the hope of finding better treatments that work specifically for patients with these tumors.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Rutgers Biomedical and Health Sciences NIH-funded |
| Lab location | 1 site (Newark, UNITED STATES) |
| Project ID | NIH-11080265 on NIH RePORTER |
What this research studies
This research focuses on understanding the role of BRCA1 and BRCA2 genes in the response of medulloblastoma, a type of brain tumor, to replication stress. By examining how these genes and their associated proteins interact, the study aims to identify unique molecular features that could lead to more effective treatments. The approach includes analyzing the genetic makeup of tumors to determine if they exhibit characteristics of 'BRCAness,' which may indicate sensitivity to specific therapies. This could pave the way for targeted treatments that are more effective than current chemotherapy and radiation options.
Who could benefit from this research
Good fit: Ideal candidates for this research are children diagnosed with medulloblastoma, particularly those with known BRCA1 or BRCA2 mutations.
Not a fit: Patients with medulloblastoma who do not have BRCA mutations or related genetic defects may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more personalized and effective treatment options for children with medulloblastoma.
How similar studies have performed: Previous research has shown promising results in targeting BRCA-related pathways in other cancers, suggesting potential for success in this area as well.
Where this research is happening
Newark, UNITED STATES
- Rutgers Biomedical and Health Sciences — Newark, United States (Active)
Researchers
- Principal investigator: Shen, Zhiyuan — Rutgers Biomedical and Health Sciences
- Study coordinator: Shen, Zhiyuan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.